Tag: UBS Securities
Sinovac gets a shot in the arm
US law firm O’Melveny & Myers represented UBS Securities and Piper Jaffray as joint book-running managers in the US$66 million follow-on public offering of NASDAQ-listed Sinovac Biotech in February
US law firm O’Melveny & Myers represented UBS Securities and Piper Jaffray as joint book-running managers in the US$66 million follow-on public offering of NASDAQ-listed Sinovac Biotech in February
In-house legal teams that adapt now will be better placed for the final judgment after the first ruling on AI training and copyright
Draft Advocates Amendment Bill 2026 could formalise law firms, mandate registration and admit foreign practices
Follow us on LinkedIn